DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial

• Julie E. Ledgerwood ,

  * E-mail: Ledgerwood@mail.nih.gov

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Abbie R. Bellamy,

  Affiliation The EMMES Corporation, Rockville, Maryland, United States of America

  ⨯
• Robert Belshe,

  Affiliation Edward A. Daisy Research Center, Saint Louis University, Saint Louis, Missouri, United States of America

  ⨯
• David I. Bernstein,

  Affiliation Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United States of America

  ⨯
• Srilatha Edupuganti,

  Affiliation Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Shital M. Patel,

  Affiliation Department of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine Houston, Texas, United States of America

  ⨯
• Phyllis Renehan,

  Affiliation The EMMES Corporation, Rockville, Maryland, United States of America

  ⨯
• Thad Zajdowicz,

  Affiliation The EMMES Corporation, Rockville, Maryland, United States of America

  ⨯
• Richard Schwartz,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Richard Koup,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Robert T. Bailer,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Galina V. Yamshchikov,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Mary E. Enama,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Uzma Sarwar,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Brenda Larkin,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Barney S. Graham,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• VRC 701 study team

  ¶Membership of VRC 701 study team is provided in the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]